Abstract 4359051: Optimal Reclassification of Aortic Aneurysms: Computed Tomography VS. Transthoracic Echocardiography

M Mohammed Abusafia (Cleveland Clinic, Cleveland, Ohio, United States) S Shada Jadam (Cleveland Clinic, Cleveland, Ohio, United States) V Vidyasagar Kalahasti (Cleveland Clinic, Cleveland, Ohio, United States) L Lifu Deng (Cleveland Clinic, Cleveland, Ohio, United States) S Susan Ospina (Cleveland Clinic, Cleveland, Ohio, United States) S Sana Sultana (Cleveland Clinic, Cleveland, Ohio, United States) A Andrew Gaballa (Cleveland Clinic, Cleveland, Ohio, United States) P Paul Schoenhagen (Cleveland Clinic, Cleveland, Ohio, United States) M Michael Bolen (Cleveland Clinic, Cleveland, Ohio, United States) B Brian Griffin (Cleveland Clinic, Cleveland, Ohio, United States) P Patrick Vargo (Cleveland Clinic, Cleveland, Ohio, United States) X Xiaoying Lou E Eric Roselli (Cleveland Clinic, Cleveland, Ohio, United States) L Lars Svensson (Cleveland Clinic, Cleveland, Ohio, United States) M Milind Desai (Cleveland Clinic, Cleveland, Ohio, United States)

Abstract

Background: Ascending aortopathy (AA) is mostly asymptomatic and often incidentally diagnosed using cardiac imaging (either transthoracic echocardiography [TTE] or computed tomographic angiography [CTA]). However, to optimally time surgical replacement, precise aortic measurements are crucial. Objective: We sought to evaluate the extent of reclassification of aortic size thresholds provided by using CTA vs. TTE in AA patients. Methods: We included 7459 patients with an unrepaired AA (≥4 cm), who underwent TTE and subsequently underwent contrast-enhanced electrocardiographically gated CTA (within 1 year of each other) between 1/2010 and 12/2023 at our large tertiary referral center. Patients presenting with an acute aortic dissection/rupture as an initial presentation were excluded (n=1188). Aortic root (AR) and mid-ascending aortic (MAA) diameters were measured on TTE and CTA. In addition, on CTA, cross sectional area to height ratios (CSAH) were measured at the AR and MAA on CTA and a threshold of ≥10 cm2/m is considered abnormal. Results: The baseline characteristics of the study population are shown in Figure 1. Figure 2 demonstrates the distribution of patients, separated on basis of 3 aortic diameter thresholds (<4.5 cm, 4.5-4.9 cm and ≥5 cm) at AR and MAA. Despite a significant correlation (r=0.80, p<0.001), TTE under-recognized an AR aneurysm (defined as ≥ 5 cm) in 646/1110 (58%) and over-estimated an aneurysm in 95/559 (17%) patients. Similarly, despite a significant correlation (r=0.79, p<0.001), TTE under-recognized an MAA aneurysm in 564/1518 (37%) and over-estimated an aneurysm in 379/1333 (28%) patients. CTA identified an additional 515 (32%) patients with an abnormal CSAH in the AR (of which 79 [15%] were women), despite the diameter in the non-aneurysmal range (<5 cm). Similarly, there were 949 (39%) patients with abnormal CSAH in the MAA (of which 383 [40%] were women), despite the diameter in the non-aneurysmal range. Conclusions: In patients with suspected AA identified on TTE, CTA appropriately reclassifies a significant proportion of patients as having an aneurysm or not. Tomographic imaging should be considered in all patients with documented AA on TTE. Additionally, CTA identified a high proportion of patients with abnormal CSAH, despite the root or ascending aortic diameters not in the aneurysmal range. This might have implications in terms of timing of appropriate surgical referral for aortic replacement, especially in women.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (15)

M

Mohammed Abusafia

Cleveland Clinic, Cleveland, Ohio, United States

S

Shada Jadam

Cleveland Clinic, Cleveland, Ohio, United States

V

Vidyasagar Kalahasti

Cleveland Clinic, Cleveland, Ohio, United States

L

Lifu Deng

Cleveland Clinic, Cleveland, Ohio, United States

S

Susan Ospina

Cleveland Clinic, Cleveland, Ohio, United States

S

Sana Sultana

Cleveland Clinic, Cleveland, Ohio, United States

A

Andrew Gaballa

Cleveland Clinic, Cleveland, Ohio, United States

P

Paul Schoenhagen

Cleveland Clinic, Cleveland, Ohio, United States

M

Michael Bolen

Cleveland Clinic, Cleveland, Ohio, United States

B

Brian Griffin

Cleveland Clinic, Cleveland, Ohio, United States

P

Patrick Vargo

Cleveland Clinic, Cleveland, Ohio, United States

X

Xiaoying Lou

E

Eric Roselli

Cleveland Clinic, Cleveland, Ohio, United States

L

Lars Svensson

Cleveland Clinic, Cleveland, Ohio, United States

M

Milind Desai

Cleveland Clinic, Cleveland, Ohio, United States